Tenax Therapeutics (TENX) Operating Leases (2019 - 2022)

Tenax Therapeutics recorded quarterly Operating Leases of $64196.0 in Q4 2022, down 69.66% quarter-over-quarter from $211590.0 in Q3 2022, and down 77.92% year-over-year from $290781.0 in Q4 2021.

Tenax Therapeutics' Operating Leases history runs 4 years deep, the most recent figure standing at $64196.0 for Q4 2022.

  • In Q4 2022, Operating Leases fell 77.92% year-over-year to $64196.0; the TTM figure through Dec 2022 stood at $64196.0 (down 77.92% YoY), while the FY2022 annual figure was $64196.0, down 77.92% from the prior year.
  • Operating Leases came in at $64196.0 for Q4 2022 at Tenax Therapeutics, down from $211590.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $315888.0 in Q3 2021 to a low of $30743.0 in Q1 2020.
  • A 4-year average of $160281.4 and a median of $131722.5 in 2019 frame the typical range for Operating Leases.
  • On a YoY basis, Operating Leases climbed as much as 0.0% in 2022 and fell as far as 77.92% in 2022.
  • Tenax Therapeutics' Operating Leases stood at $60379.0 in 2019, then slumped by 49.08% to $30743.0 in 2020, then surged by 845.84% to $290781.0 in 2021, then sank by 77.92% to $64196.0 in 2022.
  • According to Business Quant data, Operating Leases over the past three periods registered $64196.0, $211590.0, and $239039.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Tenax Therapeutics 542.72 Mn 542.72 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 64,196.00
Sep 30, 2022 211,590.00
Jun 30, 2022 239,039.00
Mar 31, 2022 155,024.00
Dec 31, 2021 290,781.00
Sep 30, 2021 315,888.00
Jun 30, 2021 239,039.00
Mar 31, 2020 30,743.00
Dec 31, 2019 60,379.00
Sep 30, 2019 108,421.00
Jun 30, 2019 105,547.00
Mar 31, 2019 102,730.00